Noesis Capital Mangement Corp Bristol Myers Squibb CO Transaction History

Noesis Capital Mangement Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $241,534 - $266,013	-3,326 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $178,373 - $207,941	3,326 New	3,326 $207,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $199,817 - $234,059	-3,377 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $2,847 - $3,101	-46 Reduced 1.34%	3,377 $225,000
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $6,705 - $7,541	-113 Reduced 3.2%	3,423 $216,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $3,406 - $3,860	59 Added 1.7%	3,536 $219,000
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $65,784 - $76,908	-1,200 Reduced 25.66%	3,477 $204,000
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $10,022 - $14,564	-216 Reduced 4.41%	4,677 $260,000
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $21,506 - $23,781	-482 Reduced 8.97%	4,893 $0
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $27,072 - $32,280	-600 Reduced 10.04%	5,375 $0
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $10,154 - $11,454	-184 Reduced 2.99%	5,975 $371,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $4,143 - $5,164	82 Added 1.35%	6,159 $341,000
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $11,984 - $13,796	-200 Reduced 3.19%	6,077 $384,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $26,373 - $28,753	-440 Reduced 6.55%	6,277 $385,000
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $2,871 - $3,314	-52 Reduced 0.77%	6,717 $428,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,769	6,769 $377,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

Stay updated on Noesis Capital Mangement Corp with notifications on news.